Elixirgen Builds Rare Disease Pipeline Around Telomere Biology Disorders and DMD

Summary

Elixirgen is building a rare disease pipeline focused on telomere biology disorders and DMD, with its lead program being an ex vivo autologous therapy targeting telomere biology disorders characterized by short telomeres and telomerase mutations.